Maxim Downgrades Vertex Pharmaceuticals After Earnings

By: via Benzinga
Analysts at Maxim Group downgraded Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Thursday from Buy to Hold and lowered their ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.